EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ferulic acid mitigates diabetic cardiomyopathy via modulation of metabolic abnormalities in cardiac tissues of diabetic rats

Veronica F Salau, Ochuko L Erukainure iD, Kolawole A Olofinsan, Nontokozo Z Msomi, Olayemi K Ijomone, Md Shahidul Islam

Fundamental & Clinical Pharmacology · 2023-02 · 37 (1) · 44-59

DOI: 10.1111/fcp.12819 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Fundamental & Clinical Pharmacology, 2022-08. Verfasst von Veronica F Salau und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, University of KwaZulu-Natal, Durban, South Africa. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetic Cardiomyopathies, Diabetes Mellitus, Experimental, Metformin. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of KwaZulu-Natal, National Research Foundation, Inyuvesi Yakwazulu-Natali.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular abnormalities have been reported as a major contributor of diabetic mortality. The protective effect of ferulic acid on diabetic cardiomyopathy in fructose‐streptozotocin induced type 2 diabetes (T2D) rat model was elucidated in this study. Type 2 diabetic rats were treated by oral administration of low (150 mg/kg b.w) and high (300 mg/kg b.w) doses of ferulic acid. Metformin was used as the antidiabetic drug. Rats were humanely euthanized after 5 weeks of treatment, and their blood and hearts were collected. Induction of T2D depleted the levels of reduced glutathione, glycogen, and HDL‐cholesterol and the activities of superoxide dismutase, catalase, ENTPDase, and 5′nucleotidase. It simultaneously triggered increase in the levels of malondialdehyde, total cholesterol, triglyceride, LDL‐cholesterol, creatinine kinase‐MB as well as activities of acetylcholinesterase, angiotensin converting enzyme (ACE), ATPase, glucose‐6‐phopsphatase, fructose‐1,6‐bisphophatase, glycogen phosphorylase, and lipase. T2D induction further revealed an obvious degeneration of cardiac muscle morphology. However, treatment with ferulic acid markedly reversed the levels and activities of these biomarkers with concomitant improvement in myocardium structural morphology, which had favorable comparison with the standard drug, metformin. Additionally, T2D induction led to the depletion of 40%, 75%, and 33% of fatty acids, fatty esters, and steroids, respectively, with concomitant generation of eicosenoic acid, gamolenic acid, and vitamin E. Ferulic acid treatment restored eicosanoic acid, 2‐hydroxyethyl ester, with concomitant generation of 6‐octadecenoic acid, (Z)‐, cis‐11‐eicosenoic acid, tridecanedioic acid, octadecanoic acid, 2‐hydroxyethyl ester, ethyl 3‐hydroxytridecanoate, dipalmitin, cholesterol isocaproate, cholest‐5‐ene, 3‐(1‐oxobuthoxy)‐, cholesta‐3,5‐diene. These results suggest the cardioprotective potential of ferulic acid against diabetic cardiomyopathy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Diabetic CardiomyopathiesDiabetes Mellitus, ExperimentalMetforminRatsAnimalsAcetylcholinesteraseOxidative StressFructoseBlood GlucoseAntioxidantsCoumaric Acids

Stichwörter der Autor:innen

cardioprotectiondiabetic cardiomyopathyferulic acidlipotoxicityoxidative stress

Substanzen

AcetylcholinesteraseMetforminFructoseBlood GlucoseAntioxidantsferulic acidCoumaric Acids

Autor:innen und Institutionen

  • Department of Biochemistry, University of KwaZulu-Natal, Durban, South Africa.
  • Department of Pharmacology, University of the Free State, Bloemfontein, South Africa.
  • Department of Anatomy, University of Medical Sciences, Ondo City, Nigeria.

ORCID-Profile: Ochuko L Erukainure

Förderung

  • University of KwaZulu-Natal
  • National Research Foundation
  • Inyuvesi Yakwazulu-Natali

Zitieren

APA

Salau, V. F., Erukainure, O. L., Olofinsan, K. A., Msomi, N. Z., Ijomone, O. K., & Islam, M. S. (2023). Ferulic acid mitigates diabetic cardiomyopathy via modulation of metabolic abnormalities in cardiac tissues of diabetic rats. Fundamental & Clinical Pharmacology, 37(1), 44-59. https://doi.org/10.1111/fcp.12819

Vancouver

Salau VF, Erukainure OL, Olofinsan KA, Msomi NZ, Ijomone OK, Islam MS. Ferulic acid mitigates diabetic cardiomyopathy via modulation of metabolic abnormalities in cardiac tissues of diabetic rats. Fundamental & Clinical Pharmacology. 2023;37(1):44-59. doi:10.1111/fcp.12819

BibTeX
@article{Salau2023,
  author = {Salau, Veronica F and Erukainure, Ochuko L and Olofinsan, Kolawole A and Msomi, Nontokozo Z and Ijomone, Olayemi K and Islam, Md Shahidul},
  title = {Ferulic acid mitigates diabetic cardiomyopathy via modulation of metabolic abnormalities in cardiac tissues of diabetic rats},
  journal = {Fundamental & Clinical Pharmacology},
  year = {2023},
  volume = {37},
  number = {1},
  pages = {44--59},
  doi = {10.1111/fcp.12819}
}
Kostenlos starten →